Insider Profile
Glickman, Richard
1
Companies Filed At
2
Open-Market Buys (2yr)
$27K
Buy Value (2yr, open-market)
Mar 09, 2026
Most Recent Trade
14
Credibility
Score
60%
Hit Rate
+9.2%
Avg 90d Return
+18.4%
Median 90d Return
5
Evaluated Trades
+20.2%
Best Trade
-6.3%
Worst Trade
Hit rate and returns are based on 5 open-market buys with evaluable 90-day outcomes. Score reflects historical conviction, not a guarantee of future performance. Limited signal — either below-average timing or insufficient trade history.
Political Donations · Elections Canada

$1K in individual political contributions across 1 donation (2017–2017).

Date Party Recipient Amount
2017-09-13 Conservative Party of Canada Conservative Party of Canada $1K

Source: Elections Canada public contribution records (individual donations only; corporate political donations have been banned federally since 2007). Matched to this insider by name — shown for transparency, not a claim of wrongdoing and not a Signal Score input.

Date Company Role Nature Dir. Shares Price Value Score
Mar 09, 2026 $EPRX
Eupraxia Pharmaceuticals
Expiry Sell 3,125 60
Mar 08, 2026 $EPRX
Eupraxia Pharmaceuticals
Expiry Sell 3,125 60
Dec 15, 2025 $EPRX
Eupraxia Pharmaceuticals
Comp. Grant Buy 10,000 $8.63 $86K 60
Dec 15, 2025 $EPRX
Eupraxia Pharmaceuticals
Comp. Grant Buy 20,000 $8.63 $173K 60
Sep 23, 2025 $EPRX
Eupraxia Pharmaceuticals
Open Market Buy 2,465 $5.50 $14K 60
Sep 23, 2025 $EPRX
Eupraxia Pharmaceuticals
Open Market Buy 2,465 $5.50 $14K 60
Mar 25, 2025 $EPRX
Eupraxia Pharmaceuticals
Comp. Grant Buy 45,000 $5.14 $231K 60
May 13, 2024 $EPRX
Eupraxia Pharmaceuticals
Comp. Grant Buy 45,000 $3.96 $178K 60
May 13, 2024 $EPRX
Eupraxia Pharmaceuticals
Comp. Grant Buy 45,000 $3.96 $178K 60
Aug 18, 2023 $EPRX
Eupraxia Pharmaceuticals
Open Market Sell 1,430 $7.00 $10K 60
Mar 09, 2021 $EPRX
Eupraxia Pharmaceuticals
Other Sell 60
Muted rows are plan purchases, compensation grants, or DRIP — not open-market. Signal scores reflect the company's current score, not the score at time of trade.
Form55 provides data and analysis for informational purposes only. Nothing on this site constitutes investment advice or a recommendation to buy or sell any security. Past performance is not indicative of future results.